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We report the ﬁrst use of whole viral genome sequencing to
identify nosocomial transmission of varicella-zoster virus with
fatal outcome. The index case patient, nursed in source isola-
tion, developed disseminated zoster with rash present for 1
day before being transferred to the intensive care unit (ICU).
Two patients who had received renal transplants while inpa-
tients in an adjacent ward developed chickenpox and 1 died;
neither patient had direct contact with the index patient.
Keywords. fatal varicella; nosocomial transmission; whole
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Varicella-zoster virus (VZV) causes both varicella and, after
latency in sensory ganglia, herpes zoster. Universal vaccina-
tion of children has reduced the incidence of varicella and
its complications in the United States, and vaccination against
zoster is available for persons aged >60 years in the United
States or >70 years in the United Kingdom. Neither vaccine
is licensed for use in immunocompromised patients, for
whom both chickenpox and herpes zoster are potentially
fatal. Because transmission is thought to arise mainly through
aerosolized virus from skin lesions, current advice in hospital
settings is to isolate patients with diagnoses of chickenpox or
widespread shingles to prevent nosocomial spread to suscepti-
ble contacts [1]. Viral genotyping provides a potential tool for
linking cases where transmission is not certain [2–4]. Howev-
er, where viruses are of the same clade [5], current genotyping
methods cannot distinguish directly transmitted viruses from
those that are unrelated or freely circulating [2]. Here we
report the use of a novel method for sequencing whole viral
genomes directly from residual diagnostic samples to conﬁrm
nosocomial transmission of fatal varicella in a renal transplant
recipient.
METHODS
Patient 1
A 55-year-old woman with end-stage renal failure caused by
renovascular disease received a cadaveric renal transplant
(MM110; donor negative/recipient positive for human cyto-
megalovirus [HCMV]), followed by basiliximab induction
and triple therapy with tacrolimus, mycophenolate mofetil,
and prednisolone. After receiving the transplant, she was an
inpatient in a 4-bed bay for 9 days. Fourteen days after dis-
charge she was readmitted into isolation with abdominal
pain, a macular rash, and abnormal liver function tests. The
rash vesiculated within 24 hours and a clinical diagnosis of
varicella was made. She was treated with intravenous acyclovir
(10 mg/kg 3 times daily), antibiotics, and cessation of immu-
nosuppression. Three days after admission she was transferred
to the ICU, where she received inotropic and ventilator
support. She died 3 days later. Varicella pneumonitis was
diagnosed, and it was noted that the patient had been VZV im-
munoglobulin (Ig) G negative before transplantation and had
not received varicella vaccine. She had had no known contact
with persons with varicella or zoster (Figure 1A; Supplemen-
tary Figure 1).
Patient 2
A 61-year-old male patient with advanced renal failure, due to
IgA nephropathy with secondary focal segmental glomerulo-
sclerosis, received a preemptive live donor renal transplant
(MM121; donor negative/recipient negative for HCMV). He
received basiliximab induction, followed by tacrolimus, my-
cophenolate mofetil, and prednisolone. Despite a history of
chickenpox in childhood he was noted to be IgG VZV nega-
tive before transplantation. He remained on the transplant
ward for 7 days. Eighteen days after discharge, he was read-
mitted to a different ward with a 4-day history of thoracic ve-
sicular rash, fever, and abnormal liver function. Disseminated
shingles was diagnosed, and the presence of VZV DNA was
conﬁrmed by polymerase chain reaction. The patient was
immediately isolated and treated with intravenous acyclovir
(10 mg/kg 3 times daily). He completed 7 days of intravenous
acyclovir, followed by 1 week of oral acyclovir. Five weeks
after the original presentation, he had further reactivation
of VZV in the L1 dermatome and received 2 further weeks
of oral acyclovir and 3 months of prophylactic treatment.
He made a full recovery and retained good graft function
(Figure 1A; Supplementary Figure 1). Importantly, a retro-
spective review indicated that disseminated shingles was a
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misdiagnosis and that recurrent varicella should have been
diagnosed.
Patient 3 (Index Case Patient)
A 67-year-old man was admitted into respiratory isolation on
the transplant ward, with cough and deteriorating renal func-
tion after dual cadaveric renal transplant 4 weeks previously.
He was isolated immediately and treated with antibiotics.
Low-grade HCMV viremia (3.92 × 102/mL) was treated with
valgancyclovir (450 mg/d). On day 10 after admission the pa-
tient was noted to have a papulovesicular rash on his right
leg. A clinical diagnosis of shingles was conﬁrmed, and treat-
ment was started with intravenous acyclovir (10 mg/kg 3
times daily). Within 24 hours, the rash became generalized, re-
spiratory failure developed, and the patient was transferred to
the ICU. He recovered with a fully functioning graft. Because
this patient was isolated and did not initially have a rash
while patient had received a diagnosis of shingles, nosocomial
transmission was not suspected. However, further investigation
after the death of patient 1 identiﬁed a period when all 3 pa-
tients had been inpatients on the same ward, albeit physically
separated from patient 3. To investigate whether the 3 cases
were linked, we genotyped and sequenced samples from all 3
patients and 2 patients with unrelated cases that occurred in
the hospital at the same time (Figure 1A, Supplementary
Figure 1).
Genotyping
Residual DNA samples were extracted using the QIAamp
DNA Mini Kit (Qiagen) according to the manufacturer’s
instructions. Ampliﬁcation and capillary sequencing of a
447–base pair region of open reading frame 22, containing 4
single-nucleotide polymorphisms (SNPs) that discriminate
between clades 1/3, 2, 4, and 5 (SNPs 37902, 38055, 38081,
and 38177) was carried out as described elsewhere [6]. In ad-
dition, the highly variable repeat region, origin of replication
(OriS), which also discriminates clade 1 from other clades, was
ampliﬁed and capillary sequenced using conditions published
elsewhere [2].
Whole-Genome Sequencing and Assembly of VZV
Sequencing libraries were constructed as described elsewhere
[7, 8] and sequenced on an Illumina MiSeq Sequencer. Data
Figure 1. A, Timeline showing hospital admissions and clinical histories for patients 1, 2, and 3. B, Neighbor-joined phylogeny (100 bootstraps) comprising the 3 linked cases
(patients 1, 2, and 3) and 2 unlinked cases (patients 3 and 4), together with 35 varicella-zoster virus database sequences obtained from GenBank. Abbreviations: Dx, diagnosis;
ICU, intensive care unit; Pt, patient; Tx, treatment.
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sets were trimmed and aligned against VZV strain Dumas
(NC_001348.1) using BWA (version 0.7.12) [9] and SAMTools
software (version 1.0) [10].Duplicate reads were removed, and a
consensus sequence for each data set generated using in-house
PERL scripts. Iterative repeat regions (R1, R2, R3, R4, and R5)
and the terminal repeat region were excluded from analyses.
OriS sequences were successfully captured within the read
data and used to verify polymerase chain reaction–based results
for all samples. Consensus sequences were aligned using MAFFT
software (version 6) [11], and a neighbor-joined phylogenetic
tree, based on the Tamura-Nei model, was inferred using
MEGA software (version 6.06) [12]. Genome sequences are avail-
able in GenBank (accession Nos. KP771912, KP771912, and 3
more awaiting assignment by GenBank as of 16 May 2016).
RESULTS
Virus from all 3 renal patients and 2 “control” patients were
typed as clade 1 by SNP genotyping, and all 5 had identical
OriS sequences. Whole-genome sequencing showed the 2 puta-
tively linked patients to be 100% identical to the index case pa-
tient, patient 3 (Figure 1B) but not the control case patients,
whose sequences contained 21 (patient 4) and 11 (patient 5)
SNP differences across the genome. Phylogenetic analysis con-
ﬁrmed the clustering of the linked cases, whereas the 2 unlinked
clade 1 viruses recovered from other patients in the hospital
clustered separately from the linked cases and from each
other (Figure 1B).
DISCUSSION
We report the use of whole viral genome sequencing to conﬁrm
an unusual case of nosocomial VZV transmission that occurred
despite source isolation of the index case patient. Although the 3
patients were in adjacent rooms for more than a week, no im-
mediate connection between them was suspected, partly be-
cause shingles was not diagnosed in the index case patient
until just before his transfer to the ICU and partly because
there was no direct contact between patients. Conventional gen-
otyping conﬁrmed all 3 patients to be infected with clade 1 vi-
ruses, the most common genotype in European populations [7].
However, SNP genotyping failed to differentiate the putatively
linked viruses from 2 epidemiologically unrelated viruses sam-
pled from other patients at about the same time. Sequencing of
highly variable regions, such as the R1 tandem repeat located in
open reading frame 11 and the OriS, has also been used to in-
vestigate nosocomial transmission [2, 8]. In the cases we report,
both linked case patients and controls had identical OriS se-
quences, and identical R1 sequences in unrelated viruses have
also been observed [2, 8].
Although amplicon sequencing to track nosocomial and
other transmission events is well established for small RNA vi-
ruses including human immunodeﬁciency virus and hepatitis C
virus [9, 13], whole-genome sequencing is required for larger
DNA viruses, because these are genetically less variable.
To this end, we have developed a method to sequence whole
pathogen genomes directly from clinical material [10]. Our
data show, unequivocally, the identity between the viruses re-
covered from the index case patient and 2 contact case patients.
The putatively linked viruses were phylogenetically distinct
from other clade 1, viruses including 1 recovered contempora-
neously in the same hospital.
Although airborne and environmental transmission of virus
from cases of zoster to distant contacts have previously been re-
ported [4], it has not hitherto been possible to conﬁrm nosoco-
mial spread, other than in rare cases where a unique signature
sequence was present in an amplicon used for SNP typing [4].
Airborne transmission despite source isolation has been de-
scribed previously, particularly where viral loads in the index
case patient are high (eg, in immunosuppressed patients and
those with hemorrhagic varicella). Thus, the need for strict
respiratory isolation of such patients, preferably in negative
pressure rooms, is paramount [4].
Our case report also underlines 2 important clinical issues.
First, primary varicella can be fatal in immunosuppressed pa-
tients despite appropriate early treatment and support. VZV an-
tibody testing and immunization against VZV in patients for
whom renal transplantation is planned has been shown to pre-
vent or attenuate varicella [14]. Second, widespread rash in an
immunosuppressed patient with a history of chickenpox, as in
our patient 2, cannot be assumed to be disseminated shingles.
Identifying cases of recurrent chickenpox due to nosocomial
transmission is important for assuring infection control mea-
sures. This case report illustrates how whole-genome sequenc-
ing can contribute to this process.
In summary, whole VZV genome sequencing directly from
clinical material provides a tractable method for monitoring nos-
ocomial transmission. Applying automated methods directly to
residual diagnostic samples, we can generate results within 5
days of sample receipt. The data provide support for the risk of
airborne transmission of VZV, especially when the viral load is
high, and underline the vulnerability of immunocompromised
patients to serious infection, irrespective of varicella history.
Our report highlights the ongoing need for vaccines that can
be prevent viral reactivation in immunocompromised patients
as an important measure for control to prevent nosocomial
spread.
Supplementary Data
Supplementary materials are available at http://jid.oxfordjournals.org.
Consisting of data provided by the author to beneﬁt the reader, the posted
materials are not copyedited and are the sole responsibility of the author, so
questions or comments should be addressed to the author.
Notes
Financial support. This work was supported by the MRC Centre for
Medical Molecular Virology, the Medical Research Foundation (New
BRIEF REPORT • JID 2016:214 (1 November) • 1401
 at U
niversity College London on D
ecem
ber 2, 2016
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
Investigator award to D. P. D.), the National Institute for Health Research
(fellowship to J. Brown), and the NIHR Biomedical Resource Centre at Uni-
versity College London Hospitals NHS Foundation Trust and University
College London (J. Breuer).
Potential conﬂicts of interest. All authors: No potential conﬂicts of in-
terest. All authors have submitted the ICMJE Form for Disclosure of Poten-
tial Conﬂicts of Interest. Conﬂicts that the editors consider relevant to the
content of the manuscript have been disclosed.
References
1. Public Health England. Shingles (herpes zoster): the green book, chapter 28a.
https://www.gov.uk/government/publications/shingles-herpes-zoster-the-green-
book-chapter-28a. Accessed September 2015.
2. Groves KC, Averbeck K, Quinlivan ML, Scott FT, Breuer J. A case of nosocominal
VZV transmission. J Clin Virol 2010; 48:226–7.
3. Molyneaux PJ, Parker S, Khan IH, Millar CG, Breuer J. Use of genomic analysis of
varicella-zoster virus to investigate suspected varicella-zoster transmission within
a renal unit. J Clin Virol 2006; 36:76–8.
4. Lopez AS, Burnett-Hartman A, Nambiar R, et al. Transmission of a newly char-
acterized strain of varicella-zoster virus from a patient with herpes zoster in a long-
term-care facility, West Virginia, 2004. J Infect Dis 2008; 197:646–53.
5. Breuer J, Grose C, Norberg P, Tipples G, Schmid DS. A proposal for a common
nomenclature for viral clades that form the species varicella-zoster virus: summary
of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine
and Dentistry, 24–25 July 2008. J Gen Virol 2010; 91:821–8.
6. Parker SP, Quinlivan M, Taha Y, Breuer J. Genotyping of varicella-zoster virus and
the discrimination of Oka vaccine strains by TaqMan real-time PCR. J Clin Micro-
biol 2006; 44:3911–4.
7. Hawrami K, Breuer J. Analysis of United Kingdom wild-type strains of varicella-
zoster virus: differentiation from the Oka vaccine strain. J Med Virol 1997;
53:60–2.
8. Hawrami K, Harper D, Breuer J. Typing of varicella zoster virus by ampliﬁcation
of DNA polymorphisms. J Virol Methods 1996; 57:169–74.
9. Li H, Stoddard MB, Wang S, et al. Single-genome sequencing of hepatitis C virus
in donor-recipient pairs distinguishes modes and models of virus transmission
and early diversiﬁcation. J Virol 2015; 90:152–66.
10. Depledge DP, Palser AL, Watson SJ, et al. Speciﬁc capture and whole-genome se-
quencing of viruses from clinical samples. PLoS One 2011; 6:e27805.
11. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evo-
lutionary genetics analysis version 6.0. Mol Biol Evol 2013; 30:2725–9.
12. Katoh K, Standley DM. MAFFT multiple sequence alignment software
version 7: improvements in performance and usability. Mol Biol Evol 2013;
30:772–80.
13. Ou CY, Ciesielski CA, Myers G, et al. Molecular epidemiology of HIV transmis-
sion in a dental practice. Science 1992; 256:1165–71.
14. Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine
in children with renal transplants. Pediatr Nephrol 1994; 8:190–2.
1402 • JID 2016:214 (1 November) • BRIEF REPORT
 at U
niversity College London on D
ecem
ber 2, 2016
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
